Evidence map›Paper›PMID 32591170›Full record

Trial reportThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2020

Targeting Cognitive Control Deficits With Neuroplasticity-Based Computerized Cognitive Remediation in Patients With Geriatric Major Depression: A Randomized, Double-Blind, Controlled Trial.

Sarah Shizuko Morimoto, Roger Alan Altizer, Faith M Gunning, Willie Hu, Jiacheng Liu, Sarah E Cote, Juliana Nitis, George S Alexopoulos

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2025
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Cognitive phenotypes in late-life depression.International psychogeriatrics · 2023
    Observational
  17. Article
  18. Article
  19. Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation Analyses.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sarah Shizuko MorimotoDepartment of Population Health Sciences, University of Utah School of Medicine, Salt Lake City UT; Weill Cornell Institute of Geriatric Psychiatry, White Plains, Salt Lake City, UT. Electronic address: sarah.morimoto@hsc.utah.edu.
Roger Alan AltizerDepartment of Population Health Sciences, University of Utah School of Medicine, Salt Lake City UT; Therapeutic Games and Apps Lab, Department of Entertainment Arts and Engineering, University of Utah, Salt Lake City, UT.
Faith M GunningWeill Cornell Institute of Geriatric Psychiatry, White Plains, Salt Lake City, UT.
Willie HuWeill Cornell Institute of Geriatric Psychiatry, White Plains, Salt Lake City, UT.
Jiacheng LiuDepartment of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, China.
Sarah E CoteDepartment of Population Health Sciences, University of Utah School of Medicine, Salt Lake City UT.
Juliana NitisWeill Cornell Institute of Geriatric Psychiatry, White Plains, Salt Lake City, UT.
George S AlexopoulosWeill Cornell Institute of Geriatric Psychiatry, White Plains, Salt Lake City, UT.
Cornell University · USUniversity of Utah · USZhongda Hospital Southeast University · CN

Funding

Computerized Cognitive Remediation in Geriatric DepressionK23MH095830 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI MORIMOTO, SARAH SHIZUKO · 2012 to 2016
$749k
NIMH NIH HHS K23 MH095830
6 · The paper itself

Abstract

Late life major depression (LLD) is often accompanied by cognitive deficits. When patients have specific deficits in cognitive control functions (CCD), they are not only distressing and debilitating, they often predict poor clinical outcomes such as reduced response to SSRI/SNRI antidepressants, increased disability, suicide and all-cause mortality. We recently reported that in an open label trial, our treatment designed to target these specific CCD with neuroplasticity-based computerized cognitive remediation (nCCR) improved depression and CCD in patients who failed to remit with conventional antidepressant treatment. This study tested the hypothesis that in patients with LLD who have failed at least one trial of an SSRI/SNRI antidepressant at an adequate dose for at least 8 weeks, nCCR will improve both depressive symptoms and the CCD associated with poor antidepressant response (i.e. semantic strategy, inhibition of prepotent responses) more than an active control group. Participants were randomized (1:1) to receive either 30 hours/ 4 weeks of neuroplasticity based computerized cognitive remediation (nCCR) designed to target CCD, or the active control condition matched for duration, engagement, reward, computer presentation, and contact with study staff. All participants and raters were blinded. Mixed effects model analysis the time effect (week) (F(1,71.22)=25.2, p<0.0001) and treatment group X time interaction (F(1,61.8)=11.37, p=.002) reached significance indicating that the slope of decline in MADRS was steeper in the nCCR-GD group. Further, the nCCR group improved their semantic clustering strategy(t(28)=9.5; p=.006), as well as performance on the Stroop interference condition, and cognitive flexibility (Trails B). Further, results transferred to memory performance, which was not a function trained by nCCR. clinicaltrials.gov.

Indexed as

Cognitive DysfunctionComputer-Aided DesignMajor Depressive DisorderNeuronal PlasticityAgedAntidepressive AgentsCognitionCognitive RemediationDouble-Blind MethodExecutive FunctionFemaleHumansMaleMemory and Learning TestsNeuropsychological TestsOutcome Assessment, Health CareAntidepressive Agentsantidepressant treatment resistancecognitive control deficitscomputerized cognitive remediationGeriatric depression

Identifiers

PMID32591170
PMCPMC12806189
OpenAlexW3031910435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.